CLINICAL_TRIALS
trial_result
· 2019-12-26
Clinical Trial Update: Dose Response Finding Study of MK-0431/ONO-5435 in Japanese Subjects With Impaired Glucose Tolerance (MK-0431-105) [Phase 2]
Summary
A Phase 2 dose-response study in Japanese subjects with impaired glucose tolerance evaluating MK-0431/ONO-5435 has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Glucose Intolerance | Phase 2 | Status: COMPLETED | Results posted: 2019-12-26